KOTK aims to fund translational research, where new research or an application in clinical practice can be initiated on the basis of the results obtained, with a view to maximizing added value for (former) cancer patients.
Budget: € 6.000.000 (in total)
Deadline: 26 September 2024 (abstract); 13 March 2025 (full-proposal)